Clinical Trials Logo

Spinal Cord Injury clinical trials

View clinical trials related to Spinal Cord Injury.

Filter by:

NCT ID: NCT05447676 Recruiting - Spinal Cord Injury Clinical Trials

Effects of 4-AP on Functional SCI Recovery

Start date: June 30, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to test a strategy to potentiate functional recovery of lower limb motor function in individuals with spinal cord injury (SCI). The FDA approved drug, Dalfampridine (4-AP). 4-AP will be used in combination of Spike-timing-dependent plasticity (STDP) stimulation and STDP stimulation with limb training.

NCT ID: NCT05433064 Recruiting - Spinal Cord Injury Clinical Trials

Spinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

NCT ID: NCT05411692 Completed - Spinal Cord Injury Clinical Trials

Functional Electrical Stimulations With and Without Motor Priming Exercises in Spinal Cord Injury

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

As functional electrical stimulations has evident role in improving motor control in tenodesis function (power and precision grip) but its results are considered to be short term so addition of task oriented approach i.e. motor priming exercises could enhance the treatment effects . Priming is a mechanism that could easily be a part of a restorative occupational therapy approach, is a therapeutic method with the intent to improve function by targeting underlying neural mechanisms (neuroplasticity and motor control). This will yield the long term effects of priming augmented functional electrical stimulations to enhance the tenodesis function of patients with spinal cord injury. Their combination may produce improvement in hand functions dexterity in spinal cord injury patients.

NCT ID: NCT05406258 Completed - Spinal Cord Injury Clinical Trials

Self-Catheterization Mirror System for Female Patients

Start date: January 11, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to test a modified mirror system for female patients to use during self-catheterization.

NCT ID: NCT05403606 Not yet recruiting - Spinal Cord Injury Clinical Trials

"Guarantee Assessment in Skin Prevention Adapted to Real Life With a Connected Device After a Spinal Cord Injury."

GASPARD-SCI
Start date: June 2022
Phase: N/A
Study type: Interventional

The investigators propose to test an embedded device on the seat of the wheelchair of paraplegic or tetraplegic patients (Gaspard), allowing on the one hand the continuous measurement of the pressures of seat, on the other hand a retro-control connected to the cell phone of the participants to inform them on these variables of seat (bad positioning, prolonged supports etc...) This study will be carried out over a long period of time (1 year), in an ergonomic situation of integration in the daily life of the participants. The main objective of this randomized controlled study is to study the difference in the incidence of pressure sores according to the use or not of this device. A qualitative study of the experience and perceived benefit of its use and a medico-economic study are associated to judge the expected interest in making this type of embedded device more systematically integrated into the classic movement equipment (wheelchair and seat cushion) of people with a spinal cord injury

NCT ID: NCT05360719 Recruiting - Spinal Cord Injury Clinical Trials

Integrated Tele-exercise for Individuals With Spinal Cord Injury

Start date: April 30, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to examine the efficacy of an integrated, participant-centered tele-health physical activity program for individuals with SCI on psychological and social factors through a parallel mixed-methods design approach. We will examine changes in psychological (self-efficacy, self-esteem, exercise outcome expectations, depression, positive affect and well-being, quality of life) and social factors (participation and satisfaction with social roles and activities, activity engagement) following participation in an 8-week integrated group tele-exercise health and wellness physical activity program, with retention assessed at 8-weeks following completion (16 weeks from baseline). We will also complete small group interviews with all participants to understand participant experiences of, response to, and recommendations before and following participation in group tele-exercise program. To date, there is extremely limited evidence for the efficacy of psychological and social well-being of remotely delivered community-based exercise to individuals with SCI. A pilot effectiveness trial of a tele-exercise health and wellness program will be conducted using a mixed methods design with a randomized waitlist control group. Quantitative and qualitative data collection is sequential in nature and other data are collected simultaneously. Individuals with SCI (living with injury 12 months or longer) will be recruited based on existing partnerships locally and nationally. To assess limited effectiveness, we aim to enroll 35 individuals with SCI. Recruitment of these participants will stem from the investigator's ongoing community partnership with local and national partners. The tele-exercise health & wellness program will consist of virtual group class, twice per week, intended to generate physical confidence and strength for individuals living with SCI. Each session will be co-led with by an individual living with SCI.

NCT ID: NCT05319522 Recruiting - Spinal Cord Injury Clinical Trials

The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury

IBSCI
Start date: May 5, 2023
Phase: N/A
Study type: Interventional

This study will examine the relationship between circulating irisin and bone health individuals with spinal cord injury. Additionally, this study seeks to examine the influence of muscle fiber type on circulating irisin and identify an exercise-based means to increase irisin concentrations.

NCT ID: NCT05308953 Completed - Spinal Cord Injury Clinical Trials

A Phase I Safety Study of NVG-291 in Healthy Adults

Start date: May 6, 2021
Phase: Phase 1
Study type: Interventional

This is a randomized, triple-blind (subjects, Investigators, and Sponsor blinded), placebo-controlled Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) study to evaluate the safety and tolerability of NVG-291 administered by subcutaneous injection daily in healthy female participants. The trial is split into three parts, starting with Part 1 (SAD), then Part 2 (MAD - post-menopausal Females), and finally Part 3 (MAD - males and premenopausal females). In Part 1 (SAD), participants receive 1 dose on 1 day only and in Parts 2 and 3, participants receive 1 dose every day for 14 days.

NCT ID: NCT05265377 Completed - Spinal Cord Injury Clinical Trials

Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury

Start date: September 21, 2022
Phase: N/A
Study type: Interventional

Gait impairment in people with acquired brain injury (ABI) and spinal cord injury (SCI) can be very heterogeneous. For this reason, STELO has been developed: a new concept of exoskeleton based on modular technology for gait assistance. It allows a personalised configuration according to the functional capacity of each patient, as the therapist can choose which robotic joints to use depending on the therapeutic goal and on the patient recovery phase. The objective is to analyse the usability of the STELO modular exoskeleton in people with ABI and SCI.

NCT ID: NCT05236933 Completed - Chronic Pain Clinical Trials

Association Between Types of Pain and Motor Activities Physical Activity

Start date: March 24, 2022
Phase:
Study type: Observational

This study will investigate the relationships between: (1) physical activity (PA) and types of chronic pain (nociceptive and neuropathic), and (2) virtual reality (VR) and types of chronic pain (nociceptive and neuropathic).